Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals
- PMID: 20182268
- DOI: 10.1097/MLR.0b013e3181ca4015
Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals
Abstract
Background: Recent guidelines recommend longer Pap test intervals. However, physicians and patients may not be adopting these recommendations.
Objectives: Identify (1) physician and practice characteristics associated with recommending a less frequent interval, and (2) characteristics associated with women's willingness to adhere to a 3-year interval.
Research design: We used 2 national surveys: (1) a 2006/2007 National Survey of Primary Care Physicians for physician cervical cancer screening practices (N = 1114), and (2) the 2005 Health Information Trends Survey for women's acceptance of longer Pap intervals (N = 2206). MEASURES AND METHODS: Physician recommendation regarding Pap intervals was measured using a clinical vignette involving a 35-year-old with no new sexual partners and 3 consecutive negative Pap tests; associations with independent variables were evaluated with logistic regression. In parallel models, we evaluated women's willingness to follow a 3-year Pap test interval.
Results: A minority of physicians (32%) have adopted-but more than half of women are willing to adopt-3-year Pap test intervals. In adjusted models, physician factors associated with less frequent screening were: serving a higher proportion of Medicaid patients, white, non-Hispanic race, fewer years since medical school graduation, and US Preventive Services Task Force being very influential in physician clinical practice. Women were more willing to follow a 3-year interval if they were older, but less willing if they had personal or family experiences with cancer or followed an annual Pap test schedule.
Conclusions: Many women are accepting of a 3-year interval for Pap tests, although most primary care physicians continue to recommend shorter intervals.
Similar articles
-
Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.J Natl Cancer Inst Monogr. 1995;(18):95-100. J Natl Cancer Inst Monogr. 1995. PMID: 8562228
-
Physician recommendation for papanicolaou testing among U.S. women, 2000.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1143-8. doi: 10.1158/1055-9965.EPI-04-0559. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894664
-
Preventive care for women. Does the sex of the physician matter?N Engl J Med. 1993 Aug 12;329(7):478-82. doi: 10.1056/NEJM199308123290707. N Engl J Med. 1993. PMID: 8332153
-
Prevalence of Cervical Cancer Overscreening: Review of a Wellness Registry.Comput Inform Nurs. 2020 Sep;38(9):459-465. doi: 10.1097/CIN.0000000000000610. Comput Inform Nurs. 2020. PMID: 32168022 Review.
-
Screening tests for adults with intellectual disabilities.J Am Board Fam Med. 2007 Jul-Aug;20(4):399-407. doi: 10.3122/jabfm.2007.04.060210. J Am Board Fam Med. 2007. PMID: 17615421 Free PMC article. Review.
Cited by
-
Assessing Intersectional Disparities in Cervical Cancer Screening by Disability Status, Race, and Ethnicity.AJPM Focus. 2022 Aug 5;1(2):100019. doi: 10.1016/j.focus.2022.100019. eCollection 2022 Dec. AJPM Focus. 2022. PMID: 37791247 Free PMC article.
-
Changing Preferences for a Cervical Cancer Screening Strategy: Moving Away from Annual Testing.Womens Health Rep (New Rochelle). 2022 Aug 4;3(1):709-717. doi: 10.1089/whr.2022.0007. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 36147829 Free PMC article.
-
De-implementation of cervical cancer screening before age 21.Prev Med. 2021 Dec;153:106815. doi: 10.1016/j.ypmed.2021.106815. Epub 2021 Sep 29. Prev Med. 2021. PMID: 34599920 Free PMC article.
-
Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.JAMA Netw Open. 2021 Apr 1;4(4):e218373. doi: 10.1001/jamanetworkopen.2021.8373. JAMA Netw Open. 2021. PMID: 33914050 Free PMC article.
-
Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests.J Low Genit Tract Dis. 2020 Apr;24(2):167-177. doi: 10.1097/LGT.0000000000000524. J Low Genit Tract Dis. 2020. PMID: 32243312 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
